I've watched every piece of video from CYDY and listened to all the CC's and in my estimation I have never see nor heard NP and especially SK, look and sound, so upbeat and confidant.
And yes NP does get overly optimistic and his timelines leave something to be desired, but I'll tell you something. I am in multiple biotech's and none of them release anywhere near the info that CYDY does, period. They're an OTC company that needs to keep it's largely retail investors up to date so they don't get grumpy and think nothing is going on.
NP has always couched most of his statements with "Maybes" and 1/2 the people on these boards take it for stated fact.
Example, last CC, NP said something to the effect that they "May" have some sales this past week. That then became "Revenue of millions would be PRed" sometime last week and when that didn't happen, It became a strike-out in a lot of peoples books. And if my memory serves, he also said in the Q&A they would report revenue in the Quarterly report or SEC filing.
What you describe as striking-out, I look at as, one step closer to hitting that home run. And after most small biotechs do hit that home run they are done for there careers, CYDY could keep hitting home runs without an R&D budget for the next 20 years with one molecule.
And yes NP does get overly optimistic and his timelines leave something to be desired, but I'll tell you something. I am in multiple biotech's and none of them release anywhere near the info that CYDY does, period. They're an OTC company that needs to keep it's largely retail investors up to date so they don't get grumpy and think nothing is going on.
NP has always couched most of his statements with "Maybes" and 1/2 the people on these boards take it for stated fact.
Example, last CC, NP said something to the effect that they "May" have some sales this past week. That then became "Revenue of millions would be PRed" sometime last week and when that didn't happen, It became a strike-out in a lot of peoples books. And if my memory serves, he also said in the Q&A they would report revenue in the Quarterly report or SEC filing.
What you describe as striking-out, I look at as, one step closer to hitting that home run. And after most small biotechs do hit that home run they are done for there careers, CYDY could keep hitting home runs without an R&D budget for the next 20 years with one molecule.
15
